The molecular mechanisms underlying erythroid-specific gene regulation remain incompletely understood. Closely spaced binding sites for GATA, NF-E2/maf, and CACCC interacting transcription factors play functionally important roles in globin and other erythroidspecific gene expression. We and others recently identified the CACCC-binding transcription factor ZBP-89 as a novel GATA-1 and NF-E2/mafK interacting partner. Here, we examined the role of ZBP-89 in human globin gene regulation and erythroid maturation using a primary CD34 ؉ cell ex vivo differentiation system. We show that ZBP-89 protein levels rise dramatically during human erythroid differentiation and that ZBP-89 occupies key cis-regulatory elements within the globin and other erythroid gene loci. ZBP-89 binding correlates strongly with RNA Pol II occupancy, active histone marks, and high-level gene expression. ZBP-89 physically associates with the histone acetyltransferases p300 and Gcn5/Trrap, and occupies common sites with Gcn5 within the human globin loci. Lentiviral short hairpin RNAs knockdown of ZBP-89 results in reduced Gcn5 occupancy, decreased acetylated histone 3 levels, lower globin and erythroid-specific gene expression, and impaired erythroid maturation. Addition of the histone deacetylase inhibitor valproic acid partially reverses the reduced globin gene expression. These findings reveal an activating role for ZBP-89 in human globin gene regulation and erythroid differentiation. (Blood. 2011;118(13):3684-3693)
IntroductionHemoglobinopathies are the most common inherited monogenic disorders worldwide. An estimated 7% of the global population are carriers, and at least 300 000 affected children are born each year. 1,2 During development, there is sequential activation and silencing of different ␣-and -like globin genes to generate developmental stage-specific hemoglobins. As -hemoglobinopathies, such as -thalassemia and sickle cell anemia, involve defects in the adult -globin gene, there has been a long-standing interest in finding means to reactivate fetal globin (␥-globin) production during adult hematopoiesis to treat these disorders. Because the clinical manifestations of thalassemias result largely from globin chain imbalance, therapeutic approaches aimed at limiting expression of the overrepresented globin gene are also expected to produce therapeutic benefits. However, incomplete knowledge of all the key transacting factors involved in normal human globin gene regulation has impeded progress in designing rational means to manipulate globin gene expression.A recurring theme in globin gene regulation is the intricate interaction of multiple sequence-specific transcription factors, such as GATA-1, Sp/KLFs, and NF-E2/maf, to recruit chromatin remodeling complexes to either activate or repress globin genes in a developmental specific manner. These factors bind to common DNA consensus motifs, GATA, CACCC-box, and MARE elements, respectively. These motifs are frequently found in close proximity to one another and are highly enriched at...